100.6 MHz): δ = 28.3, 28.4, 34.8, 37.7, 50.6, 64.2, 116.8, 123.8, 127.2, 128.0, 128.9, 129.2,
129.7, 134.3, 135.0, 145.3, 147.6, 152.3, 154.4, 155.9,192.3.
2-Amino-3-cyano-4-(2-chlorophenyl)-7,7-dimethyl-5-oxo-4H-5,6,7,8tetrahydrobenzo
[b]pyran (Table 5, entry 3)
IR (KBr) υ (cm–1): 1150, 1414, 1645, 1688, 2230, 2963, 3327, 3390.
1H NMR (CDCl3, 400 MHz) δ (ppm): 1.08, 1.13 (s, 6H, 2CH3), 2.20 and 2.26 (2H, CH2),
2.43 and 2.49 (2H, CH2), 4.63 (bs, 1H, CH), 7.14-7.33 (m, 4H, CHAr), 7.35 (bs, 2H, NH2).
13C NMR (100 MHz, DMSO-d6) δ: 27.7, 33.1, 36.7, 40.4, 50.0, 62.0, 113.0, 120.0, 126.0,
129.4, 131.4, 143.5, 159.15, 161.5, 193.0
2-Amino-3-cyano-4-(4-methylphenyl)-7,7-dimethyl-5-oxo-4H-5,6,7,8-tetrahydrobenzo
[b]pyran (Table 5, entry 2)
IR (KBr) υ (cm–1): 1414, 1470, 1603, 1681, 1683, 2199, 2875, 2959, 3197, 3330, 3471.
1H NMR (DMSO, 400 MHz) δ (ppm): 0.99 (s, 6H, 2CH3), 1.98 (1H, CH2), 2.03, (1H, CH2),
2.47 (2H, CH2), 2.94 (bs, 3H, CH3), 4.479 (s, 1H, CH), 7.62-7.94 (m, 4H, CHAr), 7.21 (bs,
13
2H, NH2). C NMR (100 MHz, DMSO-d6) δ: 23.2, 29.2, 29.2, 30.7, 36.0, 40.4, 53.2, 56.7,
113.8, 120.2, 126.0, 131.8,134.6 141.0, 159.2, 163.0, 198.8
2-Amino-3-cyano-4-(3-nitrophenyl)-7,7-dimethyl-5-oxo-4H-5,6,7,8tetrahydrobenzo [b pyran
(Table 5, entry 4)
IR (KBr) υ (cm–1): 1349, 1374, 1599, 1595, 1661, 1679, 2186, 2871, 2956, 3202, 3336, 3431.
1H NMR (400 MHz, DMSO-d6) δ: 1.03 (s, 3H, CH3), 1.08 (s, 3H, CH3), 2.4 (2H, CH2), 2.7
(2H, CH2), 4.7 (dd, 1H, CH), 7.2 (s, 2H, NH2), 7.2-7.34 (m, 4H, CHAr) 13C NMR (100 MHz,
DMSO-d6) δ: 28.5, 30.7, 37.0, 46.6, 50.0, 60.2, 113.0, 119.6, 122.5, 126.0, 130.8,135.1
145.9, 159. 9, 163.0, 198.1
2-Amino-3-cyano-4-(2-nitrophenyl)-7,7-dimethyl-5-oxo-4H-5,6,7,8-tetrahydrobenzo[b]pyran
(Table 5, entry 9)
IR (KBr) υ (cm–1): 1380, 1518, 1595, 1647, 1683, 2196, 2957, 3257, 3311.
1H NMR (DMSO-d6, 400 MHz) δ (ppm): 1.03 (s, 6H, 2CH3), 2.03 and 2.21, (2H, CH2), 2.83
13
(2H, CH2) 4.83 (bs, 1H, CH), 7.14-7.33 (m, 4H, CHAr), 7.21 (bs, 2H, NH2). C NMR (100
MHz, DMSO-d6) δ: 28.2, 28.7,. 32.6, 36.0, 40.4, 58.7, 61.0, 113.0, 117.8, 120.04, 126.0,
130.4,131.4 143.5, 159. 5, 162.6, 194.2
3 Results and discussion
In order to design and synthesize of a new and highly efficient catalyst system, The
manganese ferrite -polyoxometalate hybrid nanomaterials, MnFe2O4@SiO2@NHPhNH2-
PTA, were fabricated via a straight forward four-step procedure.(Scheme 1) Manganese
ferrite, as the magnetic core of the composite, was made by the co-precipitation of Mn2+, and
Fe3+ ions in the basic solution leading to the formation of MnFe2O4 magnetic nanoparticles
[26], and then coated with a thin layer of silica. The treatment of the silanol group of
MnFe2O4@SiO2 with 3-Chloropropyltrimethoxysilane (CPTMS) afforded MnFe2O4@SiO2-
Cl. MnFe2O4@SiO2-NHPhNH2 was carried out by the reaction of 1, 4-phenylenediamine